Eva Pérez‐Pampín

2.7k total citations
62 papers, 1.1k citations indexed

About

Eva Pérez‐Pampín is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eva Pérez‐Pampín has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Rheumatology, 23 papers in Immunology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eva Pérez‐Pampín's work include Rheumatoid Arthritis Research and Therapies (35 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Systemic Lupus Erythematosus Research (14 papers). Eva Pérez‐Pampín is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (35 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Systemic Lupus Erythematosus Research (14 papers). Eva Pérez‐Pampín collaborates with scholars based in Spain, Portugal and United States. Eva Pérez‐Pampín's co-authors include Juan J. Gómez‐Reino, Antonio González, Manuel Calaza, D. Ruiz-Montesinos, Loreto Carmona, Antonio Mera, M.Á. Descalzo, Alba Erra, Tatiana Cobo‐Ibáñez and Ariana Montes and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Eva Pérez‐Pampín

59 papers receiving 1.1k citations

Peers

Countries citing papers authored by Eva Pérez‐Pampín

Since Specialization

Citations

This map shows the geographic impact of Eva Pérez‐Pampín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Pérez‐Pampín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Pérez‐Pampín more than expected).

Fields of papers citing papers by Eva Pérez‐Pampín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Pérez‐Pampín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Pérez‐Pampín. The network helps show where Eva Pérez‐Pampín may publish in the future.

Co-authorship network of co-authors of Eva Pérez‐Pampín

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Pérez‐Pampín. A scholar is included among the top collaborators of Eva Pérez‐Pampín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Pérez‐Pampín. Eva Pérez‐Pampín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry 2024 ·Annals of the Rheumatic Diseases ·Blanca Hernández‐Cruz, (unknown), (unknown), (unknown), (unknown), Manuel José Moreno Ramos, Juan María Blanco-Madrigal, Sara Manrique‐Arija, Eva Pérez‐Pampín, D. Ruiz-Montesinos, Fernando Sánchez‐Alonso, Carlos Sánchez‐Piedra, Isabel Castrejón	13
2	Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis 2023 ·European Journal of Internal Medicine ·I. Arias de la Rosa, (unknown), (unknown), C. Pérez‐Sánchez, Fernando Leiva‐Cepas, Manuel D. Gahete, Pilar Navarro, (unknown), José Córdoba‐Chacón, Eva Pérez‐Pampín, Antonio González, Alfredo J. Lucendo, Eduardo Collantes‐Estévez, C. López-Pedrera, Alejandro Escudero‐Contreras, Nuria Barbarroja	13
3	Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression 2023 ·Arthritis Research & Therapy ·(unknown), (unknown), Eva Pérez‐Pampín, María J. Gómara, Juan Camilo Sarmiento-Monroy, (unknown), José A. Gómez‐Puerta, Antonio Mera, Carmen Conde, Raimón Sanmartí, Isabel Haro, Antonio González	0
4	Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study 2023 ·Rheumatology and Therapy ·Beatriz Joven, (unknown), Eva Pérez‐Pampín, (unknown), Raquel Almodóvar, (unknown), Joaquín Belzunegui, Estéban Rubio, Silvia Díaz‐Cerezo, Sebastián Moyano, (unknown), (unknown), Mercedes Núñez	8
5	Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice 2022 ·Digestive and Liver Disease ·Fernando Gomollón, Daniel Seoane‐Mato, Miguel Montoro, Xavier Juanola, E. Trujillo, Marta Carrillo‐Palau, (unknown), (unknown), Yolanda Ber, Laura Ramos, Eva Pérez‐Pampín, Rocío Ferreiro‐Iglesias, Lorena Rodríguez‐Alonso, (unknown), Jesús Sanz	3
6	ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis 2022 ·Frontiers in Immunology ·Ángela Rodríguez-Trillo, (unknown), Samuel García, Eva Pérez‐Pampín, (unknown), Antonio Mera, Antonio González, Carmen Conde	12
7	Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis 2018 ·Scientific Reports ·Rosario López‐Rodríguez, Aida Ferreiro-Iglesias, Áurea Lima, Miguel Bernardes, Andrzej Pawlik, Agnieszka Paradowska‐Gorycka, Jerzy Świerkot, Ryszard Ślężak, Vita Dolžan, Isidoro González‐Álvaro, Javier Narváez, Rafael Cáliz, Eva Pérez‐Pampín, Antonio Mera, Laura Vidal-Bralo, (unknown), Carmen Conde, Juan J. Gómez‐Reino, Antonio González	15
8	Objetivos y metodología de la fase iii de BIOBADASER 2017 ·Reumatología Clínica ·Carlos Sánchez‐Piedra, M.V. Hernández, Javier Manero, Rosa Roselló, (unknown), Carlos Rodríguez‐Lozano, Cristina Campos, Eduardo Cuende, J. Fernández-Lopez, Sagrario Bustabad, (unknown), Eva Pérez‐Pampín, Javier del Pino‐Montes, (unknown), Federico Díaz‐González, Juan J. Gómez‐Reino	19
9	Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response 2015 ·Pharmacogenetics and Genomics ·(unknown), Rafael Cáliz, (unknown), Helena Canhão, (unknown), Alejandro Escudero‐Contreras, Ileana Filipescu, (unknown), (unknown), Miguel Ferrer, Antonio Delgado, Luigina Romani, Eva Pérez‐Pampín, (unknown), Miguel Ángel López‐Nevot, Eduardo Collantes‐Estévez, João Eurico Fonseca, Juan Sáinz	8
10	Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs 2015 ·Pharmacogenetics and Genomics ·(unknown), Ileana Filipescu, Rafael Cáliz, (unknown), Helena Canhão, Alejandro Escudero‐Contreras, (unknown), (unknown), Miguel Ferrer, Antonio Delgado, Luigina Romani, Eva Pérez‐Pampín, (unknown), Miguel Ángel López‐Nevot, Eduardo Collantes‐Estévez, João Eurico Fonseca, Juan Sáinz	16
11	Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study 2015 ·Rheumatology International ·Alejandro Balsa, (unknown), Rafael Cáliz, (unknown), Rosario García‐Vicuña, Manuel Romero‐Gómez, (unknown), Carlos Marras, (unknown), Eva Pérez‐Pampín, (unknown)	11
12	Abatacept Therapy in Rheumatoid Arthritis With Interstitial Lung Disease 2014 ·JCR Journal of Clinical Rheumatology ·Antonio Mera, Eva Pérez‐Pampín	25
13	Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience 2013 ·Rheumatology International ·José Ramón Maneiro, Eva Pérez‐Pampín, Eva Salgado, Loreto Carmona, Juan J. Gómez‐Reino	16
14	Remission Induction in a Case of Refractory Behçet Disease With Alemtuzumab 2013 ·JCR Journal of Clinical Rheumatology ·Eva Pérez‐Pampín, J. Campos Franco, (unknown), Antonio Mera	15
15	Calcinosis cutis en una paciente con lupus eritematoso sistémico 2010 ·Reumatología Clínica ·Eva Pérez‐Pampín, J. Campos Franco, (unknown), Antonio Mera	1
16	Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study 2010 ·Arthritis Research & Therapy ·(unknown), Eva Pérez‐Pampín, Manuel Calaza, Juan J. Gómez‐Reino, Antonio González	30
17	Lack of Association with Rheumatoid Arthritis of Selected Polymorphisms in 4 Candidate Genes: CFH, CD209, Eotaxin-3, and MHC2TA 2009 ·The Journal of Rheumatology ·Rebeca Dieguez‐Gonzalez, Servet Akar, Manuel Calaza, Isidoro González‐Álvaro, Benjamín Fernández‐Gutiérrez, José Ramón Lamas, Arturo Rodríguez de la Serna, Rafael Cáliz, Francisco J. Blanco, Dora Pascual‐Salcedo, (unknown), Eva Pérez‐Pampín, José L. Pablos, Federico Navarro, Javier Narváez, Francisco Javier López‐Longo, Gabriel Herrero‐Beaumont, Juan J. Gómez‐Reino, Antonio González	16
18	All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists 2007 ·Annals of the Rheumatic Diseases ·Loreto Carmona, M.Á. Descalzo, Eva Pérez‐Pampín, D. Ruiz-Montesinos, Alba Erra, Tatiana Cobo‐Ibáñez, Juan J. Gómez‐Reino	181
19	Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study 2005 ·Arthritis Research & Therapy ·Julio A. Rodriguez‐Lopez, Eva Pérez‐Pampín, Juan J. Gómez‐Reino, Antonio González	36
20	A CTLA‐4 polymorphism associated with susceptibility to systemic lupus erythematosus 2004 ·Arthritis & Rheumatism ·(unknown), Eva Pérez‐Pampín, Juan J. Gómez‐Reino, Antonio González	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact